Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.
- DOI
- 10.1111/andr.12178
- Published
- 2016 Jul
- Container
- Andrology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/andr.12178,
title = {Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.},
author = {Trasande L and Zoeller RT and Hass U and Kortenkamp A and Grandjean P and Myers JP and DiGangi J and Hunt PM and Rudel R and Sathyanarayana S and Bellanger M and Hauser R and Legler J and Skakkebaek NE and Heindel JJ},
year = {2016},
journal = {Andrology},
doi = {10.1111/andr.12178},
url = {https://doi.org/10.1111/andr.12178}
}RIS
TY - JOUR TI - Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. AU - Trasande L AU - Zoeller RT AU - Hass U AU - Kortenkamp A AU - Grandjean P AU - Myers JP AU - DiGangi J AU - Hunt PM AU - Rudel R AU - Sathyanarayana S AU - Bellanger M AU - Hauser R AU - Legler J AU - Skakkebaek NE AU - Heindel JJ PY - 2016 JO - Andrology DO - 10.1111/andr.12178 UR - https://doi.org/10.1111/andr.12178 ER -
APA
L, T., RT, Z., U, H., A, K., P, G., JP, M., J, D., PM, H., R, R., S, S., M, B., R, H., J, L., NE, S., & JJ, H. (2016). Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.. Andrology. https://doi.org/10.1111/andr.12178
Source records
- pubmed · retrieved 2026-09-26T02:26:14.255Z